Predictive Oncology

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$2
$110
$611
$345
Gross Profit
-185
65
320
148
EBITDA
-1,978
-2,120
-1,550
-2,273
EBIT
-2,149
-2,287
-2,123
-2,313
Net Income
-2,070
-2,442
-2,169
-3,094
Net Change In Cash
2
110
611
345
Free Cash Flow
-3,294
-985
-2,060
-2,279
Cash
506
3,087
734
3,078
Basic Shares
9,108
7,152
5,453
6,396

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$1,623
$1,780
$1,505
$1,420
Gross Profit
797
1,018
1,000
933
EBITDA
-10,243
-13,182
-13,954
-12,131
EBIT
-10,939
-13,921
-15,267
-13,471
Net Income
-12,201
-13,983
-25,737
-19,657
Net Change In Cash
1,623
1,780
1,505
1,420
Free Cash Flow
-10,984
-13,491
-12,846
-13,171
Cash
734
8,728
22,071
28,202
Basic Shares
5,453
4,014
3,685
2,743

Earnings Calls

Quarter EPS
2025-06-30
-$0.22
2025-03-31
-$0.32
2024-12-31
-$0.24
2024-09-30
-$0.48